listed below are companies who we know can cover terminal conditions. As mentioned, there are lots of things that go towards the premium and acceptance criteria (for customers with or without medical conditions) such as duration of trip, location, other medical conditions and time until travel date so It cant […]
Articles from Guardian news paper on IPF.
Have you or a loved one been diagnosed with Idiopathic Pulmonary Fibrosis (IPF)? If so, we would like to know your views on IPF care in the UK. In July 2015, Action for Pulmonary Fibrosis (APF) conducted its first patient survey to assess the extent to which the NICE guidelines […]
ILD highlights from the ERS 2017 Congress, 9th September – 13th September in Milan, Italy. The presentation covers progress, new clinical trails, research updates and insights from experts in the field.
Roche’s new Esbriet tablet formulation has been approved for testing in Europe. The attached media release covers further details on the approval.
Action for Pulmonary Fibrosis is working on a project to bring together a group of 20 patients to join an impromptu choir to raise awareness of IPF, if you would like to take part please see further details below, all expenses accommodation and travel will be covered.